Literature DB >> 7898601

Death certificates: an efficient source for ascertainment of Creutzfeldt-Jakob disease cases.

Z Davanipour1, C Smoak, T Bohr, E Sobel, B Liwnicz, S Chang.   

Abstract

Case ascertainment for an epidemiologic study of Creutzfeldt-Jakob disease (CJD) can be difficult. This report investigates the efficiency of various sources of case ascertainment for CJD. Cases were identified utilizing neuropathologists, hospitals and death certificates from 11 targeted states. For the period of 1986-1988, 247 death certificates indicating a diagnosis of CJD were obtained. Only 26 potential cases were identified without death certificates. The proportion of neuropathologically confirmed cases identified by death certificates only, i.e., which were not identified through any other source, was 42%. Furthermore, 80% of all the neuropathologically confirmed cases were ascertained utilizing death certificates as a source. Of the remaining 20%, 7% were ascertained through neuropathologists only, 10% through hospitals only, 1.5% through a combination of hospitals and neuropathologists, and 1.5% through another source. The false-positive rate for death certificates with neuropathology (which may have been performed after the death certificate was filled out) was estimated to be 8.3%. The results indicate that death certificates were by far the most efficient source for initial ascertainment of potential CJD cases to be followed by verification of diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 7898601     DOI: 10.1159/000109771

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  5 in total

1.  Geographic difference of mortality of Creutzfeldt-Jakob disease in Japan.

Authors:  Yosikazu Nakamura; Makoto Watanabe; Kiwamu Nagoshi; Masahito Yamada; Hidehiro Mizusawa
Journal:  J Epidemiol       Date:  2007-01       Impact factor: 3.211

2.  Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases.

Authors:  R C Holman; A S Khan; E D Belay; L B Schonberger
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

3.  Human prion diseases in the United States.

Authors:  Robert C Holman; Ermias D Belay; Krista Y Christensen; Ryan A Maddox; Arialdi M Minino; Arianne M Folkema; Dana L Haberling; Teresa A Hammett; Kenneth D Kochanek; James J Sejvar; Lawrence B Schonberger
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

4.  Dietary Risk Factors for Sporadic Creutzfeldt-Jakob Disease: A Confirmatory Case-Control Study.

Authors:  Zoreh Davanipour; Eugene Sobel; Argyrios Ziogas; Carey Smoak; Thomas Bohr; Keith Doram; Boleslaw Liwnicz
Journal:  Br J Med Med Res       Date:  2014-04-21

5.  Ocular Tonometry and Sporadic Creutzfeldt - Jakob Disease (sCJD): A Confirmatory Case-Control Study.

Authors:  Zoreh Davanipour; Eugene Sobel; Argyrios Ziogas; Carey Smoak; Thomas Bohr; Keith Doram; Boleslaw Liwnicz
Journal:  Br J Med Med Res       Date:  2014-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.